Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fulcrum Therapeutics (FULC) Revenue: 2020-2024

Historic Revenue for Fulcrum Therapeutics (FULC) over the last 5 years, with Dec 2024 value amounting to $80.0 million.

  • Fulcrum Therapeutics' Revenue rose 8990.91% to $80.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $82.5 million, marking a year-over-year increase of 2611.47%. This contributed to the annual value of $80.0 million for FY2024, which is 2752.05% up from last year.
  • As of FY2024, Fulcrum Therapeutics' Revenue stood at $80.0 million, which was up 2,752.05% from $2.8 million recorded in FY2023.
  • In the past 5 years, Fulcrum Therapeutics' Revenue registered a high of $80.0 million during FY2024, and its lowest value of $2.8 million during FY2023.
  • Its 3-year average for Revenue is $29.7 million, with a median of $6.3 million in 2022.
  • As far as peak fluctuations go, Fulcrum Therapeutics' Revenue tumbled by 66.90% in 2022, and later skyrocketed by 2,752.05% in 2024.
  • Yearly analysis of 5 years shows Fulcrum Therapeutics' Revenue stood at $8.8 million in 2020, then spiked by 117.19% to $19.2 million in 2021, then crashed by 66.90% to $6.3 million in 2022, then plummeted by 55.77% to $2.8 million in 2023, then surged by 2,752.05% to $80.0 million in 2024.